$893.390
+2.859 (+0.32%)收盤時
MCK 資訊
MCK 事件
McKesson Corporation Discloses Cybersecurity Incident
In a regulatory filing, the company stated, "On August 25, 2026, McKesson Corporation discovered a cybersecurity incident affecting its information systems. An investigation of the incident is in its early stages. Information about the incident, including any updates, is available on the company's website at www.mckesson.com/cybersecurity. As of the date of this filing, the company has not determined that the incident is material or that the incident has had, or is reasonably likely to have, any material impact on the company, including its financial condition or results of operations."
Major Averages Rise as Chip Stocks Benefit from Nvidia Earnings
The major averages advanced, with chip stocks moving higher ahead of Nvidia's upcoming earnings print as well as key inflation data due Wednesday. The U.S. has begun imposing tougher sanctions on Iran, but crude prices have eased, continuing a downward trend that began late last week. In other geopolitical news, the North American trade war heated up as Canada is matching Trump's weekend tariff escalation with a sweeping package of counter tariffs that directly targets U.S. steel, aluminum and downstream manufacturing.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Dick's Sportingreportedand cut its FY26 earnings and revenue guidanceUnited Airlinesaddedacross Europe and AsiaMcKessonPrecision Medicine Group for roughly $2.25BTeslahas increased U.S. Cybertruck prices,Anthropic is preparing to pitch a more than $30T total addressable market in its IPO, surpassing SpaceX's$28.5T estimate,2. WALL STREET CALLS:AMDto Strong Buy from Outperform at Raymond JamesLoop CapitalFive Belowwith bullish view priced inDynatraceto Overweight at Morgan StanleyKlarnato Peer Perform at Wolfe ResearchShift4 Paymentsto Overweight at Wells Fargo3. AROUND THE WEB:Appleis set to introduce a foldable iPhone at a launch event on or around September 9, Bloomberg reportsSome PepsiCoemployees were notified this week that weight-loss drugs such as Novo Nordisk'sWegovy and Eli Lilly'sZepbound will no longer be covered by their company health insurance as of October, Bloomberg saysSoftBankis planning a record Y1T, or $6.3B, retail bond sale to raise funds for its investment commitments to OpenAI, Bloomberg saysShellhas attracted interest from ExxonMobiland LyondellBasellfor its underperforming U.S. chemicals assets, including the $14B Monaca complex, as it seeks to streamline its portfolio, FT saysJack Ma, the founder of Alibaba, has bought more than HK$600M worth of the company's Hong Kong-listed shares on consecutive days, SCMP reports4. MOVERS:Richtech Roboticsincreased after announcing aMadison Airgained after announcing aModernawas higher after Wolfe Researchthe stock to Peer PerformGorilla Technologyfell in New York afterand providing guidance for FY27Targetwas lower after issuing a statement related to its5. EARNINGS/GUIDANCE:Vipshopand provided guidance for Q3Scotiabank, with EPS and revenue beating consensusCiti Trendsand raised its outlook for FY26SelectQuote, with CEO Tim Danker commenting, "It was a highly successful 4th quarter and full-year fiscal 2026 for our business"Marzetti, with EPS beating consensusINDEXES:The Dow rose 160.24, or 0.30%, to 53,577.40, the Nasdaq gained 171.11, or 0.66%, to 26,151.30, and the S&P 500 advanced 24.42, or 0.32%, to 7,677.28.
Morgan Stanley Positive on McKesson's $2.25B Acquisition of Precision Medicine Group
Commenting on McKesson's acquisition of Precision Medicine Group for $2.25B, Morgan Stanley says the company's CRO acquisition was a long time coming. Precision Medicine Group advances McKesson's specialty strategy and expands its reach into roughly $25B oncology clinical trials and commercial services TAM, says the firm. Morgan Stanley views the deal positively as boosting an already robust oncology business. The firm has an Overweight rating on the shares with a price target of $977.
Major Averages Slightly Higher, Chip Stocks Benefit from Nvidia Earnings
The major averages were fractionally higher near noon, with chip stocks moving higher ahead of Nvidia's upcoming earnings print as well as key inflation data due Wednesday. Meanwhile, the U.S. has begun imposing tougher sanctions on Iran and is threatening countries that continue trading with Tehran, but crude prices have eased. WTI crude is hovering around $82 a barrel, continuing a downward trend that began late last week. In other geopolitical news, the North American trade war heated up as Canada is matching Trump's weekend tariff escalation with a sweeping package of counter tariffs that directly targets U.S. steel, aluminum and downstream manufacturing.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Dick's Sportingreportedand cut its FY26 earnings and revenue guidanceUnited Airlinesaddedacross Europe and AsiaMcKessonPrecision Medicine Group for roughly $2.25BBoeinghas been awarded afor the F-15 Eagle CrestTeslahas increased U.S. Cybertruck prices,2. WALL STREET CALLS:AMDto Strong Buy from Outperform at Raymond JamesLoop CapitalFive Belowwith bullish view priced inDynatraceto Overweight at Morgan StanleyKlarnato Peer Perform at Wolfe ResearchShift4 Paymentsto Overweight at Wells Fargo3. AROUND THE WEB:Ukrainian officials say Russia has used readily available NvidiaJetson Orin modules in fully autonomous AI-guided drones, highlighting how civilian Nvidia hardware can reach military applications through resale markets despite the company not selling directly in Russia, NY Times reportsSoftBankis planning a record Y1T, or $6.3B, retail bond sale to raise funds for its investment commitments to OpenAI, Bloomberg saysTaiwan prosecutors have indicted nine people, including employees from Nvidiaand Super Micro, for their involvement in the illegal export of AI servers to China, Reuters reportsShellhas attracted interest from ExxonMobiland LyondellBasellfor its underperforming U.S. chemicals assets, including the $14B Monaca complex, as it seeks to streamline its portfolio, FT saysJack Ma, the founder of Alibaba, has bought more than HK$600M worth of the company's Hong Kong-listed shares on consecutive days, SCMP reports4. MOVERS:Richtech Roboticsincreases after announcing aMadison Airgains after announcing aModernahigher after Wolfe Researchthe stock to Peer PerformGorilla Technologyfalls in New York afterand providing guidance for FY27Target) lower afterrelated to its Halloween costume following backlash5. EARNINGS/GUIDANCE:Vipshopand provided guidance for Q3Scotiabank, with EPS and revenue beating consensusCiti Trendsand raised its outlook for FY26SelectQuote, with CEO Tim Danker commenting, "It was a highly successful 4th quarter and full-year fiscal 2026 for our business"Marzetti, with EPS beating consensusINDEXES:Near midday, the Dow was up 105.54, or 0.20%, to 53,522.70, the Nasdaq was up 155.86, or 0.60%, to 26,136.05, and the S&P 500 was up 21.12, or 0.28%, to 7,673.98.
McKesson to Acquire Precision Medicine Group for Approximately $2.25B
McKesson announced that it signed a definitive agreement to acquire Precision Medicine Group, a global provider of clinical research and biopharma commercialization services. McKesson will acquire Precision Medicine Group for approximately $2.25B. Following completion of the transaction, Precision Medicine Group will report within McKesson's Oncology & Multispecialty segment. The transaction is subject to customary closing conditions, including regulatory clearances. "This acquisition represents another meaningful step in advancing our oncology and multispecialty strategy and reflects our continued commitment to providing patients with access to the highest quality of care," said Brian Tyler, chair and chief executive officer of McKesson. "Precision Medicine Group brings complementary capabilities that will enhance our clinical research and commercialization services, strengthen clinical trial execution, and broaden our clinical service offerings."
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。